Neuronetics, Inc.

3222 Phoenixville Pike

Malvern, Pennsylvania 19355

July 16, 2025

VIA EDGAR

J. Conlon Danberg

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 

Re:	Neuronetics, Inc.

Registration Statement on Form S-3 (File No. 333-288526)

Dear Mr. Danberg,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Neuronetics, Inc. (the “Registrant”) hereby requests acceleration of effectiveness of its registration statement on Form S-3 (File No. 333-288526), to 4:00 p.m., Eastern Time, on July 18, 2025, or as soon as practicable thereafter.

The Registrant requests that it be notified of such effectiveness by a telephone call to Brian D. Short of Ballard Spahr LLP at (215) 864-8230.

 

Very truly yours,
Neuronetics, Inc.
By:		/s/ W. Andrew Macan
Name:		W. Andrew Macan
Title:		Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary